AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34378087 — intervention group
Group type: EXPERIMENTAL
Intervention: CVnCoV 12μg
Number of subjects: 245
Study 34378087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 32320947 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated landing with various injury-risk profiles
Number of subjects: 35
Study 37185165 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient with comorbid depression
Number of subjects: 59
Study 33256869 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet (DG)
Number of subjects: 49
Study 33256869 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 49
Study 35371366 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee taping plus supervised exercise program
Number of subjects: 40
Study 35371366 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise program
Number of subjects: 40
Study 35371366 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups A and B
Number of subjects: 40
Study 33472432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomized trial for school reopening
Number of subjects: 0
Study 35710085 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive pretest webtool
Number of subjects: 346
Study 35710085 — intervention group
Group type: COMPARATOR
Intervention: Germline counseling
Number of subjects: 346
Study 33383492 — intervention group
Group type: EXPERIMENTAL
Intervention: CCAT + tDCS
Number of subjects: 75
Study 33383492 — intervention group
Group type: COMPARATOR
Intervention: CCAT + sham tDCS
Number of subjects: 75
Study 33383492 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 32162804 — intervention group
Group type: EXPERIMENTAL
Intervention: vanucizumab 2,000 mg plus mFOLFOX-6
Number of subjects: 189
Study 32162804 — intervention group
Group type: COMPARATOR
Intervention: bevacizumab 5 mg/kg plus mFOLFOX-6
Number of subjects: 189
Study 35445567 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel (up to 12 mg/day)
Number of subjects: 138
Study 33846498 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (IL-1 antagonist)
Number of subjects: 140
Study 33846498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (corticosteroid)
Number of subjects: 140
Study 33846498 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group in Trial B)
Number of subjects: 140
Study 35532299 — intervention group
Group type: EXPERIMENTAL
Intervention: Malarone® with ketoconazole
Number of subjects: 10
Study 35532299 — intervention group
Group type: COMPARATOR
Intervention: Malarone® alone
Number of subjects: 10
Study 32175655 — intervention group
Group type: COMPARATOR
Intervention: Efpeglenatide (2-100 μg/kg single dose)
Number of subjects: 119
Study 32175655 — intervention group
Group type: COMPARATOR
Intervention: Efpeglenatide (1, 2, or 4 mg once weekly for 8 weeks; 8, 12, or 16 mg once monthly for 9 weeks)
Number of subjects: 119
Study 32175655 — intervention group
Group type: COMPARATOR
Intervention: Efpeglenatide (various doses)
Number of subjects: 119
Study 33038014 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengue serology testing
Number of subjects: 4948
Study 35489112 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-flipped, game-based Mediterranean diet learning program (8 weeks)
Number of subjects: 0
Study 35489112 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34573983 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 1254
Study 34573983 — intervention group
Group type: COMPARATOR
Intervention: MX+US
Number of subjects: 1254
Study 35268154 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 0.5% (R0.5%)
Number of subjects: 50
Study 35268154 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg kg−1 plus ropivacaine 0.5% (MR0.5%)
Number of subjects: 50
Study 35268154 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg kg−1 plus ropivacaine 0.35% (MR0.35%)
Number of subjects: 50
Study 35268154 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg kg−1 plus ropivacaine 0.25% (MR0.25%)
Number of subjects: 50
Study 35268154 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 50
Study 34768274 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated hatha yoga (HY)
Number of subjects: 1
Study 32960654 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-10 code for alcohol-related cirrhosis (K70.3)
Number of subjects: 750
Study 32960654 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-10 code for unspecified cirrhosis (K74.6)
Number of subjects: 750
Study 32960654 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-10 code for oesophageal varices (I85.0/I85.9)
Number of subjects: 750
Study 32960654 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-10 code for hepatocellular carcinoma (HCC, C22.0)
Number of subjects: 750
Study 32960654 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-10 code for liver-related ascites (R18.9)
Number of subjects: 750
Study 32960654 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ascites code with a code for chronic liver disease
Number of subjects: 750
Study 33973407 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led consultations
Number of subjects: 280
Study 33973407 — intervention group
Group type: COMPARATOR
Intervention: Rheumatologist follow-up visits
Number of subjects: 280
Study 34243752 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic support in the form of Social Cash Transfers (SCTs) and payment of school fees
Number of subjects: 48
Study 32159722 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed acute ischemic infarct
Number of subjects: 736
Study 32159722 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke mimics
Number of subjects: 736
Study 32159722 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal imaging
Number of subjects: 736
Study 32159722 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly patients with atrial fibrillation, arterial hypertension, dysarthria, or right motor impairment
Number of subjects: 736
Study 32159722 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with low vascular risk factors, low NIHSS, decreased level of consciousness, or symptoms suggestive of posterior circulation
Number of subjects: 736
Study 32159722 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patients seen at the stroke unit
Number of subjects: 736
Study 37578599 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced computed tomography (CECT)
Number of subjects: 105
Study 37578599 — intervention group
Group type: COMPARATOR
Intervention: Non-contrast computed tomography (NCCT)
Number of subjects: 105
Study 32107571 — intervention group
Group type: EXPERIMENTAL
Intervention: D2/D3 dopamine agonist (pramipexole)
Number of subjects: 28
Study 32107571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 33856733 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocin (15 mg twice daily)
Number of subjects: 50
Study 33856733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32222135 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily) plus aspirin
Number of subjects: 6564
Study 32222135 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 6564
Study 35550342 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral, sciatic and obturator nerve blocks (group FSO) [n = 50; ropivacaine 0.75% (0.75 mg kg–1)]
Number of subjects: 88
Study 35550342 — intervention group
Group type: COMPARATOR
Intervention: Femoral, sciatic and placebo (group FSP) [n = 50; ropivacaine 0.75% (0.75 mg kg–1) and saline solution 0.9% (0.1 mL kg–1)]
Number of subjects: 88
Study 35550342 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FSO and FSP)
Number of subjects: 88
Study 33572650 — intervention group
Group type: EXPERIMENTAL
Intervention: Eco-Bio-Social (EBS) strategy including environmental management, introduction of beta fish, elimination of breeding sites, mobilization and training of community members, and community surveillance of arboviruses.
Number of subjects: 16000
Study 33572650 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 16000
Study 35879610 — intervention group
Group type: EXPERIMENTAL
Intervention: Urate-lowering therapy
Number of subjects: 0
Study 35879610 — intervention group
Group type: COMPARATOR
Intervention: Initial flares
Number of subjects: 0
Study 34592164 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg once a day for 24 weeks) + ivGCs (methylprednisolone 500 mg once a week for 6 weeks followed by 250 mg once a week for an additional six weeks)
Number of subjects: 88
Study 34592164 — intervention group
Group type: COMPARATOR
Intervention: ivGCs (methylprednisolone 500 mg once a week for 6 weeks followed by 250 mg once a week for an additional six weeks)
Number of subjects: 88
Study 35704092 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stapling techniques (SST)
Number of subjects: 272
Study 35704092 — intervention group
Group type: COMPARATOR
Intervention: Double-stapling technique (DST)
Number of subjects: 272
Study 35704092 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall morbidity and mortality
Number of subjects: 272
Study 34297336 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia using automated servo-controlled cooling devices
Number of subjects: 0
Study 34297336 — intervention group
Group type: COMPARATOR
Intervention: Standard care (normothermia)
Number of subjects: 0
Study 32070323 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D vaginal suppository (1000 units of vitamin D3)
Number of subjects: 105
Study 32070323 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal suppository
Number of subjects: 105
Study 32070323 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 105
Study 35051686 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 1433
Study 33483132 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (0.5 μg kg‐1 min‐1)
Number of subjects: 20
Study 33483132 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study 33483132 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (30-50 μg kg‐1 min‐1) in mice
Number of subjects: 20
Study 33483132 — intervention group
Group type: COMPARATOR
Intervention: Saline in mice
Number of subjects: 20
Study 34563273 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant atezolizumab after adjuvant chemotherapy
Number of subjects: 0
Study 34563273 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32331005 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (56 mg or 84 mg) in combination with newly initiated oral antidepressant (ESK+AD)
Number of subjects: 223
Study 32331005 — intervention group
Group type: COMPARATOR
Intervention: Oral antidepressant + placebo nasal spray (AD+PBO)
Number of subjects: 223
Study 35326659 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bimiralisib 2.0% gel
Number of subjects: 25
Study 35326659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 33957642 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated CO2 laser
Number of subjects: 52
Study 33957642 — intervention group
Group type: COMPARATOR
Intervention: Topical clobetasol propionate
Number of subjects: 52
Study 32797473 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg/2 weeks intramuscularly)
Number of subjects: 40
Study 32797473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35168477 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatment approaches
Number of subjects: 8
Study 34328024 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based electrical stimulation (E-Stim) therapy for 1 hour daily for 4 weeks
Number of subjects: 33
Study 34328024 — intervention group
Group type: COMPARATOR
Intervention: Control group with an identical but non-functional device for 4 weeks
Number of subjects: 33
Study 32579785 — intervention group
Group type: EXPERIMENTAL
Intervention: MA formulation (3.75 μg HA + AS03 adjuvant system)
Number of subjects: 617
Study 32579785 — intervention group
Group type: COMPARATOR
Intervention: MB formulation (3.75 μg HA + 1/2AS03)
Number of subjects: 617
Study 32579785 — intervention group
Group type: COMPARATOR
Intervention: HA formulation (7.5 μg HA + AS03)
Number of subjects: 617
Study 32579785 — intervention group
Group type: COMPARATOR
Intervention: HB formulation (7.5 μg HA + 1/2AS03)
Number of subjects: 617
Study 33892684 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination-focused cognitive behavioral therapy (RFCBT)
Number of subjects: 0
Study 33892684 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 33892684 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 0
Study 33892684 — intervention group
Group type: EXPERIMENTAL
Intervention: RFCBT
Number of subjects: 0
Study 33622643 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative story book read at least once before surgery
Number of subjects: 120
Study 33622643 — intervention group
Group type: COMPARATOR
Intervention: Non-medical, colorful story book
Number of subjects: 120
Study 33622643 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative story book read ≥3 times
Number of subjects: 120
Study 33622643 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers with low education level
Number of subjects: 120
Study 32149537 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure tone air conduction audiometry (frequencies 0.125‐8.0 kHz)
Number of subjects: 72
Study 36244853 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventional program involving motivational interviewing
Number of subjects: 268
Study 36244853 — intervention group
Group type: COMPARATOR
Intervention: Standard medication counseling
Number of subjects: 268
Study 34498222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisgender gay men in Canada
Number of subjects: 3
Study 34498222 — intervention group
Group type: EXPERIMENTAL
Intervention: Fa'afafine in Samoa
Number of subjects: 3
Study 34498222 — intervention group
Group type: EXPERIMENTAL
Intervention: Masculine muxe nguiiu in Istmo Zapotec
Number of subjects: 3
Study 34498222 — intervention group
Group type: COMPARATOR
Intervention: Feminine muxe gunaa in Istmo Zapotec
Number of subjects: 3
Study 36347946 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 dS m‐1 + Water Stress (WS)
Number of subjects: 8
Study 36347946 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 dS m‐1
Number of subjects: 8
Study 36347946 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 32253389 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive restorative system (Single Bond Universal/Z350XT) with selective enamel conditioning
Number of subjects: 50
Study 32253389 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive restorative system (Single Bond Universal/Z350XT) without selective enamel conditioning
Number of subjects: 50
Study 32253389 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement (Vitremer) with EDTA pretreatment
Number of subjects: 50
Study 32253389 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement (Vitremer) without EDTA pretreatment
Number of subjects: 50
Study 32253389 — intervention group
Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 50
Study 35420682 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (median: -0.23 kg/m2 per year)
Number of subjects: 5985
Study 35420682 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss assessed approximately 14 to 18 years preceding dementia diagnosis
Number of subjects: 5985
Study 33691142 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 158
Study 33691142 — intervention group
Group type: COMPARATOR
Intervention: Audiobooks (control)
Number of subjects: 158
Study 32955567 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36058950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratesticular (IT) administration of 10 mg/kg ZT
Number of subjects: 14
Study 36058950 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) administration of 10 mg/kg ZT
Number of subjects: 14
Study 34932104 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care supported by mHealth technology (ABC pathway)
Number of subjects: 1890
Study 34932104 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1890
Study 36113117 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze and postural stability (GPS) retraining intervention
Number of subjects: 41
Study 36113117 — intervention group
Group type: COMPARATOR
Intervention: Strength and endurance (SAE) intervention
Number of subjects: 41
Study 34103426 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulated sinusoidal currents electrophoresis of the phytocomplex
Number of subjects: 72
Study 34103426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraphonophoresis of the phytocomplex
Number of subjects: 72
Study 34103426 — intervention group
Group type: COMPARATOR
Intervention: Amplipulse therapy (modulated sinusoidal currents)
Number of subjects: 72
Study 34103426 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound therapy
Number of subjects: 72
Study 34103426 — intervention group
Group type: COMPARATOR
Intervention: Basic drug therapy
Number of subjects: 72
Study 33467603 — intervention group
Group type: EXPERIMENTAL
Intervention: Global postural re-education (GPR) therapy session (10 min session)
Number of subjects: 8
Study 32059684 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial voucher incentives (up to £400) added to usual Stop Smoking Services (SSS) support
Number of subjects: 940
Study 32059684 — intervention group
Group type: COMPARATOR
Intervention: Usual Stop Smoking Services (SSS) support alone
Number of subjects: 940
Study 35773492 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anastomotic leaks (AL)
Number of subjects: 311
Study 35773492 — intervention group
Group type: COMPARATOR
Intervention: Patients without anastomotic leaks (AL)
Number of subjects: 311
Study 34036613 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based monitoring by trained optometrists
Number of subjects: 38
Study 34036613 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based care
Number of subjects: 38
Study 32181922 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning Algorithm (YOLOv3)
Number of subjects: 50
Study 32181922 — intervention group
Group type: COMPARATOR
Intervention: POCUS Experts
Number of subjects: 50
Study 32181922 — intervention group
Group type: COMPARATOR
Intervention: POCUS Expert 1
Number of subjects: 50
Study 36003983 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 82
Study 36003983 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity active video gaming (AVG)
Number of subjects: 82
Study 32236530 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (educational session for GPs, mouse pad reminder, poster in waiting rooms)
Number of subjects: 10360
Study 32236530 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 10360
Study 32236530 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 10360
Study 35189943 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC599 12 mg
Number of subjects: 75
Study 35189943 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC599 18 mg
Number of subjects: 75
Study 35189943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 34496979 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 50 mg/week plus Methotrexate (MTX)
Number of subjects: 281
Study 35632774 — intervention group
Group type: EXPERIMENTAL
Intervention: STX-3 (3 times/day)
Number of subjects: 57
Study 35632774 — intervention group
Group type: EXPERIMENTAL
Intervention: STX-5 (5 times/day)
Number of subjects: 57
Study 35632774 — intervention group
Group type: EXPERIMENTAL
Intervention: STX-3 (3 times/day) with baseline cycle threshold values of 20–30
Number of subjects: 57
Study 35632774 — intervention group
Group type: COMPARATOR
Intervention: Control (standard therapy only)
Number of subjects: 57
Study 34287644 — intervention group
Group type: EXPERIMENTAL
Intervention: Born SGA
Number of subjects: 158
Study 34287644 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 158
Study 34613513 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmotic Release Oral System (OROS) Methylphenidate (MPH)
Number of subjects: 157
Study 34613513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 34310432 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone for 2 weeks
Number of subjects: 20
Study 34310432 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 20
Study 32066605 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief support for self-management of weight during child immunisation appointments, including weekly self-weighing and use of an online weight management programme.
Number of subjects: 80
Study 32066605 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus the intervention (brief support).
Number of subjects: 80
Study 32066605 — intervention group
Group type: COMPARATOR
Intervention: Usual care only (healthy lifestyle leaflet).
Number of subjects: 80
Study 616850836 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg genistein daily for 3-6 weeks before prostatectomy
Number of subjects: 0
Study 616850836 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules daily for 3-6 weeks before prostatectomy
Number of subjects: 0
Study 35871424 — intervention group
Group type: EXPERIMENTAL
Intervention: Video modeling based tooth-brushing education
Number of subjects: 137
Study 35871424 — intervention group
Group type: COMPARATOR
Intervention: Social story based tooth-brushing education
Number of subjects: 137
Study 34048966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for postpartum hemorrhage based on antenatal and intrapartum risk factors
Number of subjects: 9774